Pembrolizumab (KEYTRUDA)

Case Medical Research
doi 10.31525/fda1-ucm515627.htm
Full Text
Abstract

Available in full text

Date
Authors

Unknown

Publisher

Case Journals

Related search

Moving Pembrolizumab Forwards

Nature Reviews Clinical Oncology
Oncology
2020English

Pembrolizumab-Induced Bullous Pemphigoid

JAAD Case Reports
Dermatology
2019English

Pembrolizumab Microgravity Crystallization Experimentation

npj Microgravity
Materials ScienceGeneticsMolecular BiologySpaceBiochemistryPlanetary ScienceBiological SciencesMedicineAgriculturalAstronomyPhysics
2019English

Hodgkin-Lymphom: Pembrolizumab Mit Hohen Ansprechraten

Im Focus Onkologie
2017English

Urothelkarzinom: Zweitlinientherapie Mit Pembrolizumab Verlängert Überlebenszeit

Aktuelle Urologie
Urology
2019English

Pembrolizumab Yields Lasting Merkel Cell Carcinoma Responses

Cancer Discovery
Oncology
2016English

Pembrolizumab as a Treatment for PML?

Neurology: Neuroimmunology and NeuroInflammation
Neurology
2019English

Immunogenicity of Pembrolizumab in Patients With Advanced Tumors

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2019English

Pembrolizumab as First-Line Treatment for Metastatic Uveal Melanoma

Cancer Immunology, Immunotherapy
Cancer ResearchMedicineOncologyAllergyImmunology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy